Midgard Science

EpiVax

Providence, RI, United Statesepivax.comFrom their website, Nov 2026

Work here? Claim this listing

About

EpiVax provides immunogenicity assessment services for biologic and vaccine developers. It combines in silico analysis, in vitro assays, and consulting to support programs from early discovery through regulatory submission. The company is based in Providence, Rhode Island, USA.

Services

  • ISPRI™ Downselect™

    In silico service that helps identify candidates with the lowest immunogenic risk early in development.

  • ISPRI™ Quantify™

    In silico service for assessing overall and regional immunogenic and tolerogenic potential in therapeutic sequences.

  • ISPRI™ Analyze™

    In silico service for therapeutic immunogenicity analysis within the ISPRI toolkit.

  • ISPRI™ Evaluate™

    In silico service for therapeutic immunogenicity evaluation within the ISPRI toolkit.

  • ISPRI-HCP™

    In silico service focused on immunogenicity-related analysis within the ISPRI toolkit.

  • ISPRI™ Design™

    In silico service for optimizing protein regions and supporting peptide design for testing.

  • PANDA® Screening

    In silico screening service related to immunogenicity assessment.

  • iVAX™

    Web-based computational vaccine design toolkit for epitope mapping, antigen selection, immunogen design, and vaccine efficacy prediction.

7 more services
  • EpiCC™
  • PreVAX™
  • All In Vitro Assays
  • Class II HLA Binding Assay
  • Generic Peptide PANDA® Assays
  • Trusted Expert Advice (TEA)
  • IRA / ISI Regulatory Writing Support

Capabilities

Assays and studies
  • Immunogenicity
  • Peptides
  • Antibodies
  • Cell-free expression
  • ADCs
  • Cell-free in vitro assay
6 more
  • Competition-based assay
  • HLA binding assay
  • In vitro validation assay
  • Immunogenicity assessment
  • T cell epitope mapping
  • Epitope density analysis
Scale and capacity
13M+ sequences analyzed
Therapeutic areas
  • Immunogenicity assessment
  • Therapeutic development
  • Vaccine design
  • Regulatory strategy
  • Biologics
  • Antibody-drug conjugates
  • Infectious disease
  • Cancer

Instruments and platforms

  • BLAST

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • ADC
  • Peptide
  • Vaccine
Species and models
  • Humans
  • Livestock

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Type
CRO
Ownership
Woman-owned, as registered with SAM.gov or stated on their site
Address
188 Valley Street, Suite 424 Providence, RI 02909, USA
Serves
USA

Similar labs